DrugsControl Media Services

News Detail

Indian Drug Regulations Should be at par with Global Standards: NITI Ayog (16-04-2023)

New Delhi, 15 April 2023: The NITI Ayog has said that Indian drug regulatory standards should be on par with global standards. It has also recommended that medical devices should be overseen by a separate authority and not by the Drugs Controller General of India (DCGI).
View Details

Source : PTI with Inputs from Outlook
NITI Ayog Indian drug regulatory standards global standards medical devices separate authority Drugs Controller General of India (DCGI) inter-ministerial consultation New Drugs Medical Devices and Cosmetics Bill 2023 Drugs and Cosmetics Act of 1940 ICH guidelines for clinical trials timeliness of decisions promoting access of new therapies/drugs several scandals children deaths in Gambia and  Uzbekistan Indian Pharmacopoeia CDSCO

Related News